Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
University of Kentucky
University of Kentucky
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center